Gender, GH and IGF-I levels at baseline, p-VFs frequency, acromegaly outcome, GH and IGF-I levels at the last follow-up did not differ among patients carrying the d3-GHR or fl-GHR isoforms, in fg-SRLs plus Peg-V treatment group (Table 3). The gene discussed is GHR; the disease is acromegaly.